Related Experiment Video
Updated: Jun 13, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
The Alzheimer's disease mitochondrial cascade hypothesis
Russell H Swerdlow1, Jeffrey M Burns, Shaharyar M Khan
1Departments of Neurology and Molecular and Integrative Physiology, University of Kansas School of Medicine, Kansas City, KS, USA. rswerdlow@kumc.edu
The mitochondrial cascade hypothesis proposes that mitochondrial dysfunction initiates Alzheimer's disease (AD) pathologies. This theory offers alternative therapeutic targets beyond amyloid-beta, crucial for understanding sporadic, late-onset AD.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- The mitochondrial cascade hypothesis, proposed in 2004, links genetic factors to mitochondrial function and Alzheimer's disease (AD) pathogenesis.
- It posits that baseline mitochondrial durability, influenced by genetics, declines with age, initiating AD pathologies.
- This contrasts with amyloid-beta-centric models, suggesting alternative therapeutic avenues.
Purpose of the Study:
- To review evidence supporting the mitochondrial cascade hypothesis of sporadic Alzheimer's disease (AD).
- To highlight the role of mitochondrial dysfunction as a potential initiator of AD pathologies.
- To propose alternative therapeutic targets for AD based on mitochondrial function.
Main Methods:
- Review of existing scientific literature and AD endophenotype studies.
- Analysis of research linking mitochondrial function, tau phosphorylation, and amyloid-beta (Abeta) deposition.
- Evaluation of the clinical efficacy of amyloid-beta-targeting therapies.
Main Results:
- Several research lines provide data consistent with the mitochondrial cascade hypothesis.
- AD endophenotype studies indicate a significant maternal genetic contribution.
- Increasing recognition of links between mitochondrial function, tau phosphorylation, and Abeta amyloidosis.
- Limited clinical benefits observed for therapies targeting Abeta reduction.
Conclusions:
- Mitochondria are increasingly accepted as playing a critical role in late-onset Alzheimer's disease.
- The mitochondrial cascade hypothesis offers a framework for understanding sporadic AD and identifies novel therapeutic targets.
- Further investigation into mitochondrial dysfunction may advance AD research, even if the hypothesis is ultimately disproven.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
Alzheimer Disease ll: Pathophysiology
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Alzheimer Disease l: Introduction

